| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/17/2002 | CN1345312A Dibenzoazulene derivatives for treating thrombosis, osteoporosis arteriosclerosis |
| 04/17/2002 | CN1345309A Diaryl derivatives and their use as medicaments |
| 04/17/2002 | CN1345307A N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 04/17/2002 | CN1345303A Oxamic acids and derivatives as thyroid receptor ligands |
| 04/17/2002 | CN1345239A Heterocyclic containing biphenyl alpha P2 inhibitors and method |
| 04/17/2002 | CN1344755A Prep. of degradable polymer, pharmaceutical composition containing the same and its use |
| 04/17/2002 | CN1344562A Externally used cold-evil expelling prepn |
| 04/17/2002 | CN1344558A Bone invigorating composition containing yak bone and its prepn |
| 04/17/2002 | CN1344557A Kidney invigorating and arthralgia eliminating granule |
| 04/17/2002 | CN1344545A Chinese medicine prepn for treating rheumatoid arthritis and its prepn |
| 04/17/2002 | CN1344540A Application of calcium L-threonate in treating cartilage related diseases |
| 04/17/2002 | CN1082820C Purified extract of harpagophytum procumbens and/or Harpagophytum zeyherii DENCE, process for its prodn. and its use |
| 04/17/2002 | CA2358802A1 Method of treating cartilage damage |
| 04/16/2002 | US6372777 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/16/2002 | US6372776 Crystalline(−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate |
| 04/16/2002 | US6372773 Treatment of inflammation, arthritis with urea or thiourea heterocycles |
| 04/16/2002 | US6372768 2-aminopyridines containing fused ring substituents |
| 04/16/2002 | US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 04/16/2002 | US6372756 Narcotics or analgesics |
| 04/16/2002 | US6372754 Drugs for treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpic neuralgia. |
| 04/16/2002 | US6372741 Use of CSAID™ compounds as inhibitors of angiogenesis |
| 04/16/2002 | US6372739 Coumarone derivatives for drugs |
| 04/16/2002 | US6372730 2-decarboxy-2-phosphinico Prostaglandin F analogs |
| 04/16/2002 | US6372728 Formulation for treatment of osteoporosis |
| 04/16/2002 | US6372719 ανβ3 integrin antagonists in combination with chemotherapeutic agents |
| 04/16/2002 | US6372494 Culturing fibroblast cells in three-dimensions in a cell culture medium; removing conditioned medium from the cultured cells; combining conditioned medium with a pharmaceutically acceptable carrier |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
| 04/16/2002 | CA2087414C Arylcycloalkyl derivatives their production and their use |
| 04/16/2002 | CA2009690C Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029060A2 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029044A2 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002028905A2 Human anti-cd40 antibodies |
| 04/11/2002 | WO2002028904A2 Human anti-cd40 antibodies |
| 04/11/2002 | WO2002028866A2 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | WO2002028865A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028859A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028858A2 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 04/11/2002 | WO2002028856A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/11/2002 | WO2002028851A1 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 04/11/2002 | WO2002028847A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/11/2002 | WO2002028842A2 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonist |
| 04/11/2002 | WO2002028830A1 Novel phenylalanine derivatives |
| 04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | WO2002028481A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 04/11/2002 | WO2002028480A2 Methods of therapy for b-cell malignancies |
| 04/11/2002 | WO2002028434A2 Use of a ppar delta activator for treating inflammatory conditions |
| 04/11/2002 | WO2002028433A2 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 04/11/2002 | WO2002028430A2 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid |
| 04/11/2002 | WO2002028424A2 Kyberdrug as autovaccines with immune-regulating effects |
| 04/11/2002 | WO2002028413A1 Bone health compositions derived from milk |
| 04/11/2002 | WO2002028400A1 A therapeutic formulation containing glucosamine, methylsulfonymethane and eventually ascorbic acid and manganese |
| 04/11/2002 | WO2002028395A1 Phosphoric acid salt of an integrin receptor antagonist |
| 04/11/2002 | WO2002028165A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | WO2002000725A3 G-protein coupled receptor org10 |
| 04/11/2002 | WO2001090070A3 Caspase inhibitors and uses thereof |
| 04/11/2002 | WO2001090069B1 Novel calcium receptor active molecules and method for preparing same |
| 04/11/2002 | WO2001085671A3 Anthranyl amides and their use as medicaments |
| 04/11/2002 | WO2001083450A3 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| 04/11/2002 | WO2001080865A3 Joint repair using mesenchymal stem cells |
| 04/11/2002 | WO2001076572A3 Use of compatible solutes as substances having free radical scavenging properties |
| 04/11/2002 | WO2001068812A3 Methods of stimulating cartilage formation |
| 04/11/2002 | WO2001060372A3 Use of xanthine derivatives for preparing a medicine for preventing and treating osteoporosis |
| 04/11/2002 | WO2001058937A3 Interferon-alpha induced genes |
| 04/11/2002 | WO2001036374A3 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 04/11/2002 | WO2001032680A3 18-nor-steroids as selectively active estrogens |
| 04/11/2002 | WO2000052210A3 Methods for targeting rna molecules |
| 04/11/2002 | US20020042535 Therapeutic compounds and methods of use |
| 04/11/2002 | US20020042524 Process for cis-1{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy] ethyl}pyrrolidine |
| 04/11/2002 | US20020042505 Novel human ion channel protein and polynucleotides encoding the same |
| 04/11/2002 | US20020042443 Estrogen agonist / antagonist metabolites |
| 04/11/2002 | US20020042435 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/11/2002 | US20020042421 Antiinflammatory agents |
| 04/11/2002 | US20020042415 Dipeptide derivatives |
| 04/11/2002 | US20020042385 Cloning of a novel 7TM receptor AXOR-2 |
| 04/11/2002 | US20020042376 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 04/11/2002 | US20020042373 Administering thrombin receptor antagonist; bone disorders |
| 04/11/2002 | US20020042368 Integrin antagonists |
| 04/11/2002 | US20020042359 Regulators of PPARdelta (beta) and their use in the treatment of obesity and insulin resistance |
| 04/11/2002 | US20020042114 Novel human protein kinases |
| 04/11/2002 | US20020042091 Methods and compositions for screening modulators of lipid kinases |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425169A1 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | CA2425152A1 Highly expressible genes |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2424993A1 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 04/11/2002 | CA2424749A1 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | CA2424623A1 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid |
| 04/11/2002 | CA2424604A1 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | CA2424296A1 Human anti-cd40 antibodies |
| 04/11/2002 | CA2424282A1 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonist |
| 04/11/2002 | CA2424279A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/11/2002 | CA2424216A1 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |